
Syntara Limited
@syntaratx
Syntara (ASX:SNT) is an ASX-listed clinical stage drug developer for diseases linked to fibrosis and inflammation.
ID: 66560841
https://syntaratx.com.au/ 18-08-2009 01:51:28
453 Tweet
450 Followers
231 Following


“This would be the first approved drug that’s modifying the whole way that a scar develops.” Thank you to 7NEWS Australia and reporter Amber Laidler for covering our work to change what’s possible in the treatment of scarring. Our next-generation topical anti-fibrotic drug is










Syntara advances #myelofibrosis trial with Phase 2 data and SNT-5505 FDA fast track designation | $SNT Media coverage by Small Caps. smallcaps.com.au/syntara-myelof… #myelofibrosis #SNT #Syntara #Biotech




WHO grants official INN for Syntara’s clinical development asset SNT-5505 | Media coverage by AusBiotech. biotechdispatch.com.au/news/who-grant… $SNT #Syntara #Biotech